Featured Research

from universities, journals, and other organizations

Herpes Virus Can Be Used As Nanomachines For Cancer Treatment

Date:
October 17, 2007
Source:
Louisiana State University
Summary:
Herpes viruses, though not life-threatening, are usually considered to be embarrassing and annoying. Researchers have now found a way to use the virus to potentially fight breast cancer, which, according to the American Cancer Society, is the most common cancer among women. In fact, excluding cancers of the skin, breast cancer accounts for nearly one in three cancers diagnosed in U.S. women.

Sections of breast cancers growing after implantation in mice were prepared for pathological examination. Panel A shows a breast cancer from a mouse that received the killed virus injection (control). Panel B shows a breast cancer from a mouse that received a liquid that was used to dilute the virus (control). Panel C shows a breast cancer from a mouse that received the live cancer fighting herpes virus. In panel C, it can be seen that breast cancer cells have been killed (Necrotic N) compared to panels A and B in which cancer cells are viable.
Credit: Image courtesy of Louisiana State University

Herpes viruses, though not life-threatening, are usually considered to be embarrassing and annoying. Researchers at the LSU School of Veterinary Medicine, however, are using the virus to potentially fight breast cancer, which, according to the American Cancer Society, is the most common cancer among women.

In fact, excluding cancers of the skin, breast cancer accounts for nearly one in three cancers diagnosed in U.S. women.

“Our immune systems are engineered to fight cancer,” said Dr. Konstantin “Gus” Kousoulas, professor of virology in the Department of Pathobiological Sciences and director of the Division of Biotechnology & Molecular Medicine. “The human body’s T-cells belong to a group of white blood cells and play a central role in immunity. However, cancer cells cause the T-cells to essentially fall asleep.

“The tumor emits signals to down-regulate the T-cells. Our herpes virus can be engineered to awaken those cells and modulate the immune system so that it recognizes the tumor cells and destroys them.”

The herpes virus was engineered to selectively replicate in cancer cells; it does not affect normal cells.

“Herpes virus replicate cells on their own,” said Kousoulas. “Cold sores are caused when the herpes virus replicates and kills normal cells; the cold sore is made up of the dead cells. Our herpes virus has been engineered to only replicate and destroy cancer cells, thus killing the tumor. Patients would not contract the herpes virus itself.”

The next step is to show that LSU’s virus can enhance the immune system. Besides destroying cancer cells, this herpes virus also has the potential to work as a vaccine.

“The herpes virus is oncolytic, which means it kills the tumor, but we want to see now if it can be engineered to boost the immune system and prevent it from metastasizing,” said Kousoulas.

Kousoulas is collaborating with Dr. Augusto Ochoa, a world-renowned authority on cancer immunology and interim director of the Stanley S. Scott Cancer Center, which is part of the LSU Health Sciences Center in New Orleans, Louisiana. The two are working on the next phase of the study with support from the Louisiana Cancer Consortium.

A German company, MediGene, has a similar herpes virus, which is in Phase 3 clinical trials for liver cancer.

“MediGene has seen significant results,” said Kousoulas, “and their trial should be completed within six months.”

Kousoulas, however, believes that LSU’s virus has been improved to go beyond the capabilities of MediGene’s virus.

“Our virus has been engineered to spread even better among cancer cells,” he said. “It causes the cancer cells to fuse together so that the virus can then destroy the cells more efficiently. The virus can be used as a vector to express other genes. We can insert multiple genes into it to enhance its tumor-killing capabilities.”

Kousoulas recently discussed this exciting new research at the 4th International Workshop on Nanosciences and Nanotechnologies at Aristotle University in Thessaloniki, Greece. Part of the study has also been published in the May 2007 issue of Human Gene Therapy (Israyelyan, et al).

“History shows us that cancer cannot be treated using pharmaceuticals alone,” said Kousoulas. “We have to look at new and innovative gene therapies if we are to move forward.”

The study is in the pre-clinical experiment phase right now. Qyntessa Biologics, part of the Louisiana Emerging Technologies Center on the LSU campus in Baton Rouge, Louisiana, is preparing to produce these viruses under strict Food & Drug Administration guidelines called Good Manufacturing Practices, or GMP.

The LSU School of Veterinary Medicine and the Stanley S. Scott Cancer Center will work with Qyntessa to get the virus to Phase 1 human experiments, for initial toxicological evaluation. Phase 2 experiments expand the testing to a handful of patients, and Phase 3 testing uses 100 to 200 patients. It will take at least three years to get to the Phase 3 testing stage. Financial support for these studies has been obtained from the National Institutes of Health, The Louisiana Board of Regents Biotechnology Initiative, the Louisiana Cancer Consortium, and the Louisiana Gene Therapy Program of the LSU Health Sciences Center in New Orleans.


Story Source:

The above story is based on materials provided by Louisiana State University. Note: Materials may be edited for content and length.


Cite This Page:

Louisiana State University. "Herpes Virus Can Be Used As Nanomachines For Cancer Treatment." ScienceDaily. ScienceDaily, 17 October 2007. <www.sciencedaily.com/releases/2007/10/071016093219.htm>.
Louisiana State University. (2007, October 17). Herpes Virus Can Be Used As Nanomachines For Cancer Treatment. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2007/10/071016093219.htm
Louisiana State University. "Herpes Virus Can Be Used As Nanomachines For Cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/2007/10/071016093219.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins